Patrick O’Brien

Contatto Relazioni con gli Investitori presso PARDES BIOSCIENCES, INC.

Health Technology

Consumer Services

Profilo

Patrick O’Brien currently works at Pardes Biosciences, Inc., as Senior Vice President-Investor Relations.
Mr. O’Brien also formerly worked at Gilead Sciences, Inc., as Vice President-Investor Relations, Ligand Pharmaceuticals, Inc., as Investor Relations Contact, and Vir Biotechnology, Inc., as Investor Relations Contact.
Mr. O’Brien received his undergraduate degree from Loyola University New Orleans and Masters Business Admin degree from Kellogg School of Management.

Posizioni attive di Patrick O’Brien

Società	Posizione	Inizio
PARDES BIOSCIENCES, INC.	Contatto Relazioni con gli Investitori	-

Tutte le posizioni attive di Patrick O’Brien

Precedenti posizioni note di Patrick O’Brien

Società	Posizione	Fine
VIR BIOTECHNOLOGY, INC.	Contatto Relazioni con gli Investitori	-
GILEAD SCIENCES, INC.	Contatto Relazioni con gli Investitori	-
LIGAND PHARMACEUTICALS INCORPORATED	Public Communications Contact	-

Vedi nel dettaglio l'esperienza di Patrick O’Brien

Formazione di Patrick O’Brien

Loyola University New Orleans	Undergraduate Degree
Kellogg School of Management	Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Patrick O’Brien

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	3
LIGAND PHARMACEUTICALS INCORPORATED	Health Technology
VIR BIOTECHNOLOGY, INC.	Health Technology
GILEAD SCIENCES, INC.	Health Technology

Aziende private	1
Pardes Biosciences, Inc. Pardes Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Pardes Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing and commercializing novel therapeutics to treat and prevent viral diseases. It also focuses on developing novel drugs to solve pandemic-sized problems like the coronavirus disease. The company was founded by Uri A. Lopatin and Lee D. Arnold on February 27, 2020 and is headquartered in Carlsbad, CA.	Health Technology